Compare DOMO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOMO | OSUR |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 477.0M | 177.2M |
| IPO Year | 2018 | 1986 |
| Metric | DOMO | OSUR |
|---|---|---|
| Price | $8.87 | $2.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $14.38 | $3.00 |
| AVG Volume (30 Days) | ★ 1.1M | 676.8K |
| Earning Date | 12-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $318,002,000.00 | $125,703,000.00 |
| Revenue This Year | $2.28 | N/A |
| Revenue Next Year | $2.45 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.01 | $2.08 |
| 52 Week High | $18.49 | $4.22 |
| Indicator | DOMO | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 46.98 |
| Support Level | $8.63 | $2.41 |
| Resistance Level | $9.22 | $2.49 |
| Average True Range (ATR) | 0.50 | 0.10 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 32.19 | 27.12 |
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.